Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(immunotherapy). Showing records 1 – 30 of 870 total matches.

[1] [2] [3] [4] [5] … [29]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters

1. Khare, Priyanka. Attenuation of gonadotropin secreting tumors by immunotherapy.

Degree: 2009, Jamia Hamdard University

newline Advisors/Committee Members: Javed, Saleem.

Subjects/Keywords: Immunotherapy

Page 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Khare, P. (2009). Attenuation of gonadotropin secreting tumors by immunotherapy. (Thesis). Jamia Hamdard University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/37387

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Khare, Priyanka. “Attenuation of gonadotropin secreting tumors by immunotherapy.” 2009. Thesis, Jamia Hamdard University. Accessed September 19, 2019. http://shodhganga.inflibnet.ac.in/handle/10603/37387.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Khare, Priyanka. “Attenuation of gonadotropin secreting tumors by immunotherapy.” 2009. Web. 19 Sep 2019.

Vancouver:

Khare P. Attenuation of gonadotropin secreting tumors by immunotherapy. [Internet] [Thesis]. Jamia Hamdard University; 2009. [cited 2019 Sep 19]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/37387.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Khare P. Attenuation of gonadotropin secreting tumors by immunotherapy. [Thesis]. Jamia Hamdard University; 2009. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/37387

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. Sunay, Melek ME. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.

Degree: 2015, Johns Hopkins University

 The tumor microenvironment is established and maintained through the complex interactions of tumor cells with host stromal elements. Therefore, therapies that target multiple cellular components… (more)

Subjects/Keywords: immunotherapy. cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sunay, M. M. (2015). Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/38006

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sunay, Melek ME. “Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.” 2015. Thesis, Johns Hopkins University. Accessed September 19, 2019. http://jhir.library.jhu.edu/handle/1774.2/38006.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sunay, Melek ME. “Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy.” 2015. Web. 19 Sep 2019.

Vancouver:

Sunay MM. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. [Internet] [Thesis]. Johns Hopkins University; 2015. [cited 2019 Sep 19]. Available from: http://jhir.library.jhu.edu/handle/1774.2/38006.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sunay MM. Harnessing Mechanisms of Immune Modulation by Sorafenib to Augment the Efficacy of Cellular Immunotherapy. [Thesis]. Johns Hopkins University; 2015. Available from: http://jhir.library.jhu.edu/handle/1774.2/38006

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Hong Kong

3. 黃心龍; Wong, Sum-lung. The use of immunotherapy in solid tumours : efficacy and toxicity.

Degree: Master of Research in Medicine, Medicine, 2017, University of Hong Kong

Immune checkpoint inhibitors are revolutionising cancer care worldwide. However, local data regarding the efficacy and toxicity of these agents is scarce. This is a single… (more)

Subjects/Keywords: Immunotherapy - Tumors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

黃心龍; Wong, S. (2017). The use of immunotherapy in solid tumours : efficacy and toxicity. (Masters Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/252496

Chicago Manual of Style (16th Edition):

黃心龍; Wong, Sum-lung. “The use of immunotherapy in solid tumours : efficacy and toxicity.” 2017. Masters Thesis, University of Hong Kong. Accessed September 19, 2019. http://hdl.handle.net/10722/252496.

MLA Handbook (7th Edition):

黃心龍; Wong, Sum-lung. “The use of immunotherapy in solid tumours : efficacy and toxicity.” 2017. Web. 19 Sep 2019.

Vancouver:

黃心龍; Wong S. The use of immunotherapy in solid tumours : efficacy and toxicity. [Internet] [Masters thesis]. University of Hong Kong; 2017. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10722/252496.

Council of Science Editors:

黃心龍; Wong S. The use of immunotherapy in solid tumours : efficacy and toxicity. [Masters Thesis]. University of Hong Kong; 2017. Available from: http://hdl.handle.net/10722/252496


University of Hong Kong

4. Ho, Hoi-hang. Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models.

Degree: PhD, 2012, University of Hong Kong

Fumagillin is the natural product isolated from fungus Aspergillus fumigatus, and is recognized as a potent anti-angiogenic compound. Substantial investigation has been focused on the… (more)

Subjects/Keywords: Cancer - Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ho, H. (2012). Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. (Doctoral Dissertation). University of Hong Kong. Retrieved from Ho, H. [何凱恆]. (2012). Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5060560 ; http://dx.doi.org/10.5353/th_b5060560 ; http://hdl.handle.net/10722/198805

Chicago Manual of Style (16th Edition):

Ho, Hoi-hang. “Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models.” 2012. Doctoral Dissertation, University of Hong Kong. Accessed September 19, 2019. Ho, H. [何凱恆]. (2012). Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5060560 ; http://dx.doi.org/10.5353/th_b5060560 ; http://hdl.handle.net/10722/198805.

MLA Handbook (7th Edition):

Ho, Hoi-hang. “Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models.” 2012. Web. 19 Sep 2019.

Vancouver:

Ho H. Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. [Internet] [Doctoral dissertation]. University of Hong Kong; 2012. [cited 2019 Sep 19]. Available from: Ho, H. [何凱恆]. (2012). Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5060560 ; http://dx.doi.org/10.5353/th_b5060560 ; http://hdl.handle.net/10722/198805.

Council of Science Editors:

Ho H. Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. [Doctoral Dissertation]. University of Hong Kong; 2012. Available from: Ho, H. [何凱恆]. (2012). Study of fumagillin analogues on murine immune cells and immunomodulatory effects in different cancer models. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5060560 ; http://dx.doi.org/10.5353/th_b5060560 ; http://hdl.handle.net/10722/198805


University of Hong Kong

5. Tan, Zhiwu. Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice.

Degree: PhD, 2014, University of Hong Kong

 Malignant mesothelioma is an aggressive cancer with increasing incidence worldwide. Exposure to asbestos is believed to be the main mechanistic basis of malignant transformation of… (more)

Subjects/Keywords: Mesothelioma - Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tan, Z. (2014). Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. (Doctoral Dissertation). University of Hong Kong. Retrieved from Tan, Z. [譚志武]. (2014). Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5317026 ; http://dx.doi.org/10.5353/th_b5317026 ; http://hdl.handle.net/10722/206430

Chicago Manual of Style (16th Edition):

Tan, Zhiwu. “Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice.” 2014. Doctoral Dissertation, University of Hong Kong. Accessed September 19, 2019. Tan, Z. [譚志武]. (2014). Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5317026 ; http://dx.doi.org/10.5353/th_b5317026 ; http://hdl.handle.net/10722/206430.

MLA Handbook (7th Edition):

Tan, Zhiwu. “Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice.” 2014. Web. 19 Sep 2019.

Vancouver:

Tan Z. Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. [Internet] [Doctoral dissertation]. University of Hong Kong; 2014. [cited 2019 Sep 19]. Available from: Tan, Z. [譚志武]. (2014). Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5317026 ; http://dx.doi.org/10.5353/th_b5317026 ; http://hdl.handle.net/10722/206430.

Council of Science Editors:

Tan Z. Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. [Doctoral Dissertation]. University of Hong Kong; 2014. Available from: Tan, Z. [譚志武]. (2014). Vaccine-elicited CD8⁺ T cells overcome immune suppressive environment to cure malignant mesothelioma in mice. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5317026 ; http://dx.doi.org/10.5353/th_b5317026 ; http://hdl.handle.net/10722/206430


Vanderbilt University

6. Shae, Daniel. Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.

Degree: PhD, Chemical Engineering, 2019, Vanderbilt University

 I detail the rational design and optimization of STING-NPs: a nanoparticle delivery platform that stimulates innate immunity and T cell activation through targeted activation of… (more)

Subjects/Keywords: Cancer Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shae, D. (2019). Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://etd.library.vanderbilt.edu/available/etd-03042019-120929/ ;

Chicago Manual of Style (16th Edition):

Shae, Daniel. “Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.” 2019. Doctoral Dissertation, Vanderbilt University. Accessed September 19, 2019. http://etd.library.vanderbilt.edu/available/etd-03042019-120929/ ;.

MLA Handbook (7th Edition):

Shae, Daniel. “Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy.” 2019. Web. 19 Sep 2019.

Vancouver:

Shae D. Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. [Internet] [Doctoral dissertation]. Vanderbilt University; 2019. [cited 2019 Sep 19]. Available from: http://etd.library.vanderbilt.edu/available/etd-03042019-120929/ ;.

Council of Science Editors:

Shae D. Design and Optimization of âSmartâ Nanoparticles for Targeting of the STING Pathway with Applications in Cancer Immunotherapy. [Doctoral Dissertation]. Vanderbilt University; 2019. Available from: http://etd.library.vanderbilt.edu/available/etd-03042019-120929/ ;


Rice University

7. Evans, Emily Reiser. Gold Nanovaccine Strategies for Cancer Immunotherapy.

Degree: PhD, Engineering, 2018, Rice University

 Gold nanoparticles have excellent properties for cancer therapeutics because their tunable size and surface chemistry make them customizable for many applications. For immunotherapy applications in… (more)

Subjects/Keywords: nanoparticle; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Evans, E. R. (2018). Gold Nanovaccine Strategies for Cancer Immunotherapy. (Doctoral Dissertation). Rice University. Retrieved from http://hdl.handle.net/1911/105658

Chicago Manual of Style (16th Edition):

Evans, Emily Reiser. “Gold Nanovaccine Strategies for Cancer Immunotherapy.” 2018. Doctoral Dissertation, Rice University. Accessed September 19, 2019. http://hdl.handle.net/1911/105658.

MLA Handbook (7th Edition):

Evans, Emily Reiser. “Gold Nanovaccine Strategies for Cancer Immunotherapy.” 2018. Web. 19 Sep 2019.

Vancouver:

Evans ER. Gold Nanovaccine Strategies for Cancer Immunotherapy. [Internet] [Doctoral dissertation]. Rice University; 2018. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1911/105658.

Council of Science Editors:

Evans ER. Gold Nanovaccine Strategies for Cancer Immunotherapy. [Doctoral Dissertation]. Rice University; 2018. Available from: http://hdl.handle.net/1911/105658


University of Minnesota

8. Murphy, Katherine Anne. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.

Degree: PhD, Molecular, Cellular, Developmental Biology and Genetics, 2012, University of Minnesota

 Glioblastoma multiforme, the most aggressive form of glioma, is a lethal brain tumor with a dismal median survival of 15-19 months. Immunotherapy is a promising… (more)

Subjects/Keywords: Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Murphy, K. A. (2012). Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. (Doctoral Dissertation). University of Minnesota. Retrieved from http://purl.umn.edu/151476

Chicago Manual of Style (16th Edition):

Murphy, Katherine Anne. “Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.” 2012. Doctoral Dissertation, University of Minnesota. Accessed September 19, 2019. http://purl.umn.edu/151476.

MLA Handbook (7th Edition):

Murphy, Katherine Anne. “Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma.” 2012. Web. 19 Sep 2019.

Vancouver:

Murphy KA. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. [Internet] [Doctoral dissertation]. University of Minnesota; 2012. [cited 2019 Sep 19]. Available from: http://purl.umn.edu/151476.

Council of Science Editors:

Murphy KA. Immune-based tumor regression induced by Fc-OX40L in a murine model of glioma. [Doctoral Dissertation]. University of Minnesota; 2012. Available from: http://purl.umn.edu/151476


University of Victoria

9. Little, Nicole S. Investigating the co-evolution of tumor antigens and the anti-tumor immune response.

Degree: Department of Biochemistry and Microbiology, 2017, University of Victoria

 Background: High-grade serous carcinoma (HGSC) can exhibit high intratumoral heterogeneity (ITH). Despite a strong association between tumor-infiltrating lymphocytes (TIL) and survival in HGSC, ITH may… (more)

Subjects/Keywords: Cancer; Cancer Immunotherapy; Ovarian Cancer; Immunology; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Little, N. S. (2017). Investigating the co-evolution of tumor antigens and the anti-tumor immune response. (Masters Thesis). University of Victoria. Retrieved from https://dspace.library.uvic.ca//handle/1828/8503

Chicago Manual of Style (16th Edition):

Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Masters Thesis, University of Victoria. Accessed September 19, 2019. https://dspace.library.uvic.ca//handle/1828/8503.

MLA Handbook (7th Edition):

Little, Nicole S. “Investigating the co-evolution of tumor antigens and the anti-tumor immune response.” 2017. Web. 19 Sep 2019.

Vancouver:

Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Internet] [Masters thesis]. University of Victoria; 2017. [cited 2019 Sep 19]. Available from: https://dspace.library.uvic.ca//handle/1828/8503.

Council of Science Editors:

Little NS. Investigating the co-evolution of tumor antigens and the anti-tumor immune response. [Masters Thesis]. University of Victoria; 2017. Available from: https://dspace.library.uvic.ca//handle/1828/8503


Georgia Tech

10. Campbell, Elizabeth. Janus Particles Designed for Cancer Immunotherapy.

Degree: PhD, Biomedical Engineering (Joint GT/Emory Department), 2018, Georgia Tech

 Although CD8+ T cells commonly migrate to solid tumors, cancer cells suppress and evade these cells through a variety of intrinsic and extrinsic mechanisms. As… (more)

Subjects/Keywords: Particles; Janus particles; cancer immunotherapy; immunoengineering; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Campbell, E. (2018). Janus Particles Designed for Cancer Immunotherapy. (Doctoral Dissertation). Georgia Tech. Retrieved from http://hdl.handle.net/1853/61676

Chicago Manual of Style (16th Edition):

Campbell, Elizabeth. “Janus Particles Designed for Cancer Immunotherapy.” 2018. Doctoral Dissertation, Georgia Tech. Accessed September 19, 2019. http://hdl.handle.net/1853/61676.

MLA Handbook (7th Edition):

Campbell, Elizabeth. “Janus Particles Designed for Cancer Immunotherapy.” 2018. Web. 19 Sep 2019.

Vancouver:

Campbell E. Janus Particles Designed for Cancer Immunotherapy. [Internet] [Doctoral dissertation]. Georgia Tech; 2018. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1853/61676.

Council of Science Editors:

Campbell E. Janus Particles Designed for Cancer Immunotherapy. [Doctoral Dissertation]. Georgia Tech; 2018. Available from: http://hdl.handle.net/1853/61676


University of Hong Kong

11. Kwok, Yim. Is immunotherapy effective for asthma prevention? : a systematic review.

Degree: MPH, 2016, University of Hong Kong

Background: Asthma is a chronic allergic disease causing significant morbidity to patients. Recent studies showed that allergen immunotherapy may be an effective prevention measure for… (more)

Subjects/Keywords: Asthma - Prevention; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kwok, Y. (2016). Is immunotherapy effective for asthma prevention? : a systematic review. (Masters Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/237256

Chicago Manual of Style (16th Edition):

Kwok, Yim. “Is immunotherapy effective for asthma prevention? : a systematic review.” 2016. Masters Thesis, University of Hong Kong. Accessed September 19, 2019. http://hdl.handle.net/10722/237256.

MLA Handbook (7th Edition):

Kwok, Yim. “Is immunotherapy effective for asthma prevention? : a systematic review.” 2016. Web. 19 Sep 2019.

Vancouver:

Kwok Y. Is immunotherapy effective for asthma prevention? : a systematic review. [Internet] [Masters thesis]. University of Hong Kong; 2016. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10722/237256.

Council of Science Editors:

Kwok Y. Is immunotherapy effective for asthma prevention? : a systematic review. [Masters Thesis]. University of Hong Kong; 2016. Available from: http://hdl.handle.net/10722/237256


University of Otago

12. Bouwer, Anthea Lynne. Role of NK cells in DC-based immunotherapy of melanoma .

Degree: 2011, University of Otago

 Natural killer (NK) cells were first identified by their ability to kill tumour or virally infected cells without prior sensitization. In spite of this, the… (more)

Subjects/Keywords: NK cells; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bouwer, A. L. (2011). Role of NK cells in DC-based immunotherapy of melanoma . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/1619

Chicago Manual of Style (16th Edition):

Bouwer, Anthea Lynne. “Role of NK cells in DC-based immunotherapy of melanoma .” 2011. Doctoral Dissertation, University of Otago. Accessed September 19, 2019. http://hdl.handle.net/10523/1619.

MLA Handbook (7th Edition):

Bouwer, Anthea Lynne. “Role of NK cells in DC-based immunotherapy of melanoma .” 2011. Web. 19 Sep 2019.

Vancouver:

Bouwer AL. Role of NK cells in DC-based immunotherapy of melanoma . [Internet] [Doctoral dissertation]. University of Otago; 2011. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10523/1619.

Council of Science Editors:

Bouwer AL. Role of NK cells in DC-based immunotherapy of melanoma . [Doctoral Dissertation]. University of Otago; 2011. Available from: http://hdl.handle.net/10523/1619


Victoria University of Wellington

13. Hunn, Martin Kent. Improving immunotherapy for high grade glioma.

Degree: 2015, Victoria University of Wellington

 Glioblastoma multiforme (GBM) is a malignant primary brain tumour that is almost always fatal. Conventional treatment modalities are limited by toxicity. T cell-based immunotherapy is… (more)

Subjects/Keywords: Glioma; Immunotherapy; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hunn, M. K. (2015). Improving immunotherapy for high grade glioma. (Doctoral Dissertation). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/4869

Chicago Manual of Style (16th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Doctoral Dissertation, Victoria University of Wellington. Accessed September 19, 2019. http://hdl.handle.net/10063/4869.

MLA Handbook (7th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Web. 19 Sep 2019.

Vancouver:

Hunn MK. Improving immunotherapy for high grade glioma. [Internet] [Doctoral dissertation]. Victoria University of Wellington; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10063/4869.

Council of Science Editors:

Hunn MK. Improving immunotherapy for high grade glioma. [Doctoral Dissertation]. Victoria University of Wellington; 2015. Available from: http://hdl.handle.net/10063/4869


University of Otago

14. Win, Stephanie Joy. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .

Degree: 2011, University of Otago

 Virus-like particles (VLP) have been shown to be useful nanoscale platforms in a diverse range of applications including their use as vaccines. They can act… (more)

Subjects/Keywords: Virus-Like Particles; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Win, S. J. (2011). Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/1733

Chicago Manual of Style (16th Edition):

Win, Stephanie Joy. “Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .” 2011. Doctoral Dissertation, University of Otago. Accessed September 19, 2019. http://hdl.handle.net/10523/1733.

MLA Handbook (7th Edition):

Win, Stephanie Joy. “Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles .” 2011. Web. 19 Sep 2019.

Vancouver:

Win SJ. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . [Internet] [Doctoral dissertation]. University of Otago; 2011. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10523/1733.

Council of Science Editors:

Win SJ. Inducing Anti-Tumor Immune Responses with Antigen Conjugated Virus-Like Particles . [Doctoral Dissertation]. University of Otago; 2011. Available from: http://hdl.handle.net/10523/1733

15. Hu, Hong-Ming. Priming of therapeutic T cells for adoptive immunotherapy.

Degree: PhD, 2003, Oregon Health Sciences University

Subjects/Keywords: Immunotherapy; Adoptive

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hu, H. (2003). Priming of therapeutic T cells for adoptive immunotherapy. (Doctoral Dissertation). Oregon Health Sciences University. Retrieved from doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146

Chicago Manual of Style (16th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Doctoral Dissertation, Oregon Health Sciences University. Accessed September 19, 2019. doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

MLA Handbook (7th Edition):

Hu, Hong-Ming. “Priming of therapeutic T cells for adoptive immunotherapy.” 2003. Web. 19 Sep 2019.

Vancouver:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Internet] [Doctoral dissertation]. Oregon Health Sciences University; 2003. [cited 2019 Sep 19]. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146.

Council of Science Editors:

Hu H. Priming of therapeutic T cells for adoptive immunotherapy. [Doctoral Dissertation]. Oregon Health Sciences University; 2003. Available from: doi:10.6083/M4HX19ZF ; http://digitalcommons.ohsu.edu/etd/3146


Georgia State University

16. Cacan, Ercan. Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity.

Degree: PhD, Biology, 2015, Georgia State University

  Chemotherapy and radiation therapy remain the backbone of cancer treatments, and now cancer immunotherapy offers promising new approaches for the treatment of malignancies. One… (more)

Subjects/Keywords: Chemoresistance; Immunotherapy; Epigenetics; Radiation; Proteasome

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cacan, E. (2015). Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity. (Doctoral Dissertation). Georgia State University. Retrieved from https://scholarworks.gsu.edu/biology_diss/156

Chicago Manual of Style (16th Edition):

Cacan, Ercan. “Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity.” 2015. Doctoral Dissertation, Georgia State University. Accessed September 19, 2019. https://scholarworks.gsu.edu/biology_diss/156.

MLA Handbook (7th Edition):

Cacan, Ercan. “Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity.” 2015. Web. 19 Sep 2019.

Vancouver:

Cacan E. Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity. [Internet] [Doctoral dissertation]. Georgia State University; 2015. [cited 2019 Sep 19]. Available from: https://scholarworks.gsu.edu/biology_diss/156.

Council of Science Editors:

Cacan E. Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity. [Doctoral Dissertation]. Georgia State University; 2015. Available from: https://scholarworks.gsu.edu/biology_diss/156


University of Plymouth

17. Goddard, Ruth Victoria. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.

Degree: PhD, 2002, University of Plymouth

Immunotherapy using dendritic cells has shown encouraging results in both haematological and non-haematological malignancies. In this study, monocyte-derived dendritic cells from patients with B-cell Chronic… (more)

Subjects/Keywords: 616; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Goddard, R. V. (2002). Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. (Doctoral Dissertation). University of Plymouth. Retrieved from http://hdl.handle.net/10026.1/2695

Chicago Manual of Style (16th Edition):

Goddard, Ruth Victoria. “Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.” 2002. Doctoral Dissertation, University of Plymouth. Accessed September 19, 2019. http://hdl.handle.net/10026.1/2695.

MLA Handbook (7th Edition):

Goddard, Ruth Victoria. “Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells.” 2002. Web. 19 Sep 2019.

Vancouver:

Goddard RV. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. [Internet] [Doctoral dissertation]. University of Plymouth; 2002. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10026.1/2695.

Council of Science Editors:

Goddard RV. Generation of in vitro B-cell chronic lymphocytic leukaemia-specific T cell responses using dendritic cells. [Doctoral Dissertation]. University of Plymouth; 2002. Available from: http://hdl.handle.net/10026.1/2695

18. Šilanskas, Mantas. Oncolytic viruses armed with immunostimulatory genes for cancer treatment.

Degree: Biology Education Centre, 2018, Uppsala UniversityUppsala University

  Cancer is a major health burden in modern society, costing millions of lives worldwide and negatively impacting many more. With increasing rates of cancer,… (more)

Subjects/Keywords: Cancer; Virus; Immunotherapy; Immunology; Immunologi

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Šilanskas, M. (2018). Oncolytic viruses armed with immunostimulatory genes for cancer treatment. (Thesis). Uppsala UniversityUppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Šilanskas, Mantas. “Oncolytic viruses armed with immunostimulatory genes for cancer treatment.” 2018. Thesis, Uppsala UniversityUppsala University. Accessed September 19, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Šilanskas, Mantas. “Oncolytic viruses armed with immunostimulatory genes for cancer treatment.” 2018. Web. 19 Sep 2019.

Vancouver:

Šilanskas M. Oncolytic viruses armed with immunostimulatory genes for cancer treatment. [Internet] [Thesis]. Uppsala UniversityUppsala University; 2018. [cited 2019 Sep 19]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Šilanskas M. Oncolytic viruses armed with immunostimulatory genes for cancer treatment. [Thesis]. Uppsala UniversityUppsala University; 2018. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353153

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Saskatchewan

19. Tomporowski, Jason Scott. Improving the biological activity of CpG ODN by linking it to carbon nanotubes.

Degree: 2010, University of Saskatchewan

 Preventative immunotherapeutic treatments have been an area of great interest to combat infectious disease because of the ability to stimulate the host’s immune system which… (more)

Subjects/Keywords: Carbon nanotube; CpG ODN; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tomporowski, J. S. (2010). Improving the biological activity of CpG ODN by linking it to carbon nanotubes. (Thesis). University of Saskatchewan. Retrieved from http://hdl.handle.net/10388/etd-01142010-103203

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tomporowski, Jason Scott. “Improving the biological activity of CpG ODN by linking it to carbon nanotubes.” 2010. Thesis, University of Saskatchewan. Accessed September 19, 2019. http://hdl.handle.net/10388/etd-01142010-103203.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tomporowski, Jason Scott. “Improving the biological activity of CpG ODN by linking it to carbon nanotubes.” 2010. Web. 19 Sep 2019.

Vancouver:

Tomporowski JS. Improving the biological activity of CpG ODN by linking it to carbon nanotubes. [Internet] [Thesis]. University of Saskatchewan; 2010. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10388/etd-01142010-103203.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tomporowski JS. Improving the biological activity of CpG ODN by linking it to carbon nanotubes. [Thesis]. University of Saskatchewan; 2010. Available from: http://hdl.handle.net/10388/etd-01142010-103203

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


McMaster University

20. Afsahi, Arya. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.

Degree: MSc, 2015, McMaster University

Introduction: Manipulation of the immune system to eliminate cancer, known as cancer immunotherapy, is an emerging field that has shown impressive clinical success and promise.… (more)

Subjects/Keywords: Immunology; T cell; Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Afsahi, A. (2015). Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. (Masters Thesis). McMaster University. Retrieved from http://hdl.handle.net/11375/18413

Chicago Manual of Style (16th Edition):

Afsahi, Arya. “Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.” 2015. Masters Thesis, McMaster University. Accessed September 19, 2019. http://hdl.handle.net/11375/18413.

MLA Handbook (7th Edition):

Afsahi, Arya. “Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells.” 2015. Web. 19 Sep 2019.

Vancouver:

Afsahi A. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. [Internet] [Masters thesis]. McMaster University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/11375/18413.

Council of Science Editors:

Afsahi A. Development of novel chimeric receptors for delivery of costimulation to tumor-reactive engineered T cells. [Masters Thesis]. McMaster University; 2015. Available from: http://hdl.handle.net/11375/18413


University of Illinois – Urbana-Champaign

21. Harris, Daniel Thomas. Engineering and characterizing human T cell receptors for cancer immunotherapies.

Degree: PhD, Biochemistry, 2016, University of Illinois – Urbana-Champaign

 The T cell receptor (TCR) is an heterodimer that binds to a short peptide bound to a product of the major histocompatibility complex (MHC). The… (more)

Subjects/Keywords: Immunotherapy; T Cell Receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harris, D. T. (2016). Engineering and characterizing human T cell receptors for cancer immunotherapies. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/95531

Chicago Manual of Style (16th Edition):

Harris, Daniel Thomas. “Engineering and characterizing human T cell receptors for cancer immunotherapies.” 2016. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed September 19, 2019. http://hdl.handle.net/2142/95531.

MLA Handbook (7th Edition):

Harris, Daniel Thomas. “Engineering and characterizing human T cell receptors for cancer immunotherapies.” 2016. Web. 19 Sep 2019.

Vancouver:

Harris DT. Engineering and characterizing human T cell receptors for cancer immunotherapies. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2016. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/2142/95531.

Council of Science Editors:

Harris DT. Engineering and characterizing human T cell receptors for cancer immunotherapies. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2016. Available from: http://hdl.handle.net/2142/95531


Boston University

22. Kim, Susie. Recent advancements in cancer immunotherapeutics.

Degree: MS, Medical Sciences, 2015, Boston University

 Cancer affects a wide range of organs and tissues within the body and epidemiologically is forecasted to affect almost half of the world's population. As… (more)

Subjects/Keywords: Medicine; Cancer; Immunotherapy; Review

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, S. (2015). Recent advancements in cancer immunotherapeutics. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/16217

Chicago Manual of Style (16th Edition):

Kim, Susie. “Recent advancements in cancer immunotherapeutics.” 2015. Masters Thesis, Boston University. Accessed September 19, 2019. http://hdl.handle.net/2144/16217.

MLA Handbook (7th Edition):

Kim, Susie. “Recent advancements in cancer immunotherapeutics.” 2015. Web. 19 Sep 2019.

Vancouver:

Kim S. Recent advancements in cancer immunotherapeutics. [Internet] [Masters thesis]. Boston University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/2144/16217.

Council of Science Editors:

Kim S. Recent advancements in cancer immunotherapeutics. [Masters Thesis]. Boston University; 2015. Available from: http://hdl.handle.net/2144/16217


Drexel University

23. Arhontoulis, Dimitrios C. Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12.

Degree: 2016, Drexel University

Various forms of immunotherapy have arisen and shown promise in treating cancer. The administration of cytokines such as Interleukin-12 (IL-12) was thought to robustly stimulate… (more)

Subjects/Keywords: Biomedical engineering; Cancer – Immunotherapy; Interleukins

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arhontoulis, D. C. (2016). Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12. (Thesis). Drexel University. Retrieved from http://hdl.handle.net/1860/idea:6834

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Arhontoulis, Dimitrios C. “Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12.” 2016. Thesis, Drexel University. Accessed September 19, 2019. http://hdl.handle.net/1860/idea:6834.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Arhontoulis, Dimitrios C. “Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12.” 2016. Web. 19 Sep 2019.

Vancouver:

Arhontoulis DC. Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12. [Internet] [Thesis]. Drexel University; 2016. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1860/idea:6834.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Arhontoulis DC. Tumor Microenvironment-Responsive Nanogel for Therapeutic Delivery of Interleukin-12. [Thesis]. Drexel University; 2016. Available from: http://hdl.handle.net/1860/idea:6834

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Oxford

24. Calderon, Hugo. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.

Degree: PhD, 2017, University of Oxford

 Oncolytic viruses are characterised by their ability to selectively infect and kill tumour cells. Recently it has emerged that they can exert an additional anticancer… (more)

Subjects/Keywords: Oncology; Cancer; Immunotherapy; Oncolytic virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calderon, H. (2017). Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889

Chicago Manual of Style (16th Edition):

Calderon, Hugo. “Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.” 2017. Doctoral Dissertation, University of Oxford. Accessed September 19, 2019. http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889.

MLA Handbook (7th Edition):

Calderon, Hugo. “Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response.” 2017. Web. 19 Sep 2019.

Vancouver:

Calderon H. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. [Internet] [Doctoral dissertation]. University of Oxford; 2017. [cited 2019 Sep 19]. Available from: http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889.

Council of Science Editors:

Calderon H. Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response. [Doctoral Dissertation]. University of Oxford; 2017. Available from: http://ora.ox.ac.uk/objects/uuid:da89b317-5f76-4447-bbb1-26740db3b3ef ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748889


Cornell University

25. Chandrasekaran, Siddarth. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis .

Degree: 2015, Cornell University

 Metastasis of primary tumor accounts for 90% of all deaths in cancer patients. Interaction between cells in the primary tumor is known to play an… (more)

Subjects/Keywords: Cancer Metastasis; Drug Delivery; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chandrasekaran, S. (2015). Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis . (Thesis). Cornell University. Retrieved from http://hdl.handle.net/1813/41158

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chandrasekaran, Siddarth. “Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis .” 2015. Thesis, Cornell University. Accessed September 19, 2019. http://hdl.handle.net/1813/41158.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chandrasekaran, Siddarth. “Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis .” 2015. Web. 19 Sep 2019.

Vancouver:

Chandrasekaran S. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis . [Internet] [Thesis]. Cornell University; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1813/41158.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chandrasekaran S. Engineering Approaches To Analyze And Target Cancer Invasion And Metastasis . [Thesis]. Cornell University; 2015. Available from: http://hdl.handle.net/1813/41158

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

26. Dockery, Mary Diana. Focused Ultrasound for the Generation of Cancer Immunotherapy.

Degree: MS, Biomedical Engineering, 2016, Vanderbilt University

 Cancer immunotherapies, which seek to arm the patient’s own immune system for personalized therapy, are a promising option for effective elimination of tumors. Focused ultrasound… (more)

Subjects/Keywords: immunotherapy; focused ultrasound; breast cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dockery, M. D. (2016). Focused Ultrasound for the Generation of Cancer Immunotherapy. (Masters Thesis). Vanderbilt University. Retrieved from http://etd.library.vanderbilt.edu/available/etd-11212016-145818/ ;

Chicago Manual of Style (16th Edition):

Dockery, Mary Diana. “Focused Ultrasound for the Generation of Cancer Immunotherapy.” 2016. Masters Thesis, Vanderbilt University. Accessed September 19, 2019. http://etd.library.vanderbilt.edu/available/etd-11212016-145818/ ;.

MLA Handbook (7th Edition):

Dockery, Mary Diana. “Focused Ultrasound for the Generation of Cancer Immunotherapy.” 2016. Web. 19 Sep 2019.

Vancouver:

Dockery MD. Focused Ultrasound for the Generation of Cancer Immunotherapy. [Internet] [Masters thesis]. Vanderbilt University; 2016. [cited 2019 Sep 19]. Available from: http://etd.library.vanderbilt.edu/available/etd-11212016-145818/ ;.

Council of Science Editors:

Dockery MD. Focused Ultrasound for the Generation of Cancer Immunotherapy. [Masters Thesis]. Vanderbilt University; 2016. Available from: http://etd.library.vanderbilt.edu/available/etd-11212016-145818/ ;


University of California – San Francisco

27. Williams, Jasper Zee. Engineering T cells with diverse mechanisms for improved tumor recognition precision.

Degree: Pharmaceutical Sciences and Pharmacogenomics, 2019, University of California – San Francisco

 Engineered T cells are proven cancer therapeutics capable of executing potent antigen-dependent cell killing, and have gained FDA-approval after unprecedented results against certain blood cancers.… (more)

Subjects/Keywords: Pharmaceutical sciences; Antigens; Cancer; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Williams, J. Z. (2019). Engineering T cells with diverse mechanisms for improved tumor recognition precision. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/0zn3g33t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Williams, Jasper Zee. “Engineering T cells with diverse mechanisms for improved tumor recognition precision.” 2019. Thesis, University of California – San Francisco. Accessed September 19, 2019. http://www.escholarship.org/uc/item/0zn3g33t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Williams, Jasper Zee. “Engineering T cells with diverse mechanisms for improved tumor recognition precision.” 2019. Web. 19 Sep 2019.

Vancouver:

Williams JZ. Engineering T cells with diverse mechanisms for improved tumor recognition precision. [Internet] [Thesis]. University of California – San Francisco; 2019. [cited 2019 Sep 19]. Available from: http://www.escholarship.org/uc/item/0zn3g33t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Williams JZ. Engineering T cells with diverse mechanisms for improved tumor recognition precision. [Thesis]. University of California – San Francisco; 2019. Available from: http://www.escholarship.org/uc/item/0zn3g33t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

28. Berinstein, Elliot. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.

Degree: 2016, University of Toronto

The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a promising treatment for various cancers. CARs have been shown to redirect… (more)

Subjects/Keywords: Cancer; Gene Therapy; Immunotherapy; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Berinstein, E. (2016). The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/90143

Chicago Manual of Style (16th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Masters Thesis, University of Toronto. Accessed September 19, 2019. http://hdl.handle.net/1807/90143.

MLA Handbook (7th Edition):

Berinstein, Elliot. “The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1.” 2016. Web. 19 Sep 2019.

Vancouver:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/1807/90143.

Council of Science Editors:

Berinstein E. The Development Of A Novel Chimeric Antigen Receptor Specific For Syndecan-1. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/90143

29. O'donnell, Kyle. Avian IgY As An Immunotherapy For Flaviviral Infections.

Degree: PhD, Biomedical Sciences, 2019, University of North Dakota

  Flaviviruses compose a group of positive single strand RNA viruses. This group possess 70 individual viruses that cause disease in humans and animals. This… (more)

Subjects/Keywords: Dengue; Flavivirus; IgY; Immunotherapy; Zika

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

O'donnell, K. (2019). Avian IgY As An Immunotherapy For Flaviviral Infections. (Doctoral Dissertation). University of North Dakota. Retrieved from https://commons.und.edu/theses/2478

Chicago Manual of Style (16th Edition):

O'donnell, Kyle. “Avian IgY As An Immunotherapy For Flaviviral Infections.” 2019. Doctoral Dissertation, University of North Dakota. Accessed September 19, 2019. https://commons.und.edu/theses/2478.

MLA Handbook (7th Edition):

O'donnell, Kyle. “Avian IgY As An Immunotherapy For Flaviviral Infections.” 2019. Web. 19 Sep 2019.

Vancouver:

O'donnell K. Avian IgY As An Immunotherapy For Flaviviral Infections. [Internet] [Doctoral dissertation]. University of North Dakota; 2019. [cited 2019 Sep 19]. Available from: https://commons.und.edu/theses/2478.

Council of Science Editors:

O'donnell K. Avian IgY As An Immunotherapy For Flaviviral Infections. [Doctoral Dissertation]. University of North Dakota; 2019. Available from: https://commons.und.edu/theses/2478


Victoria University of Wellington

30. Cameron, Alanna. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.

Degree: 2015, Victoria University of Wellington

 Metastatic melanoma is the most aggressive form of skin cancer, associated with a poor prognosis, and the incidence worldwide is increasing. Recently, selective mutant BRAF… (more)

Subjects/Keywords: Melanoma; Immunotherapy; BRAF inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cameron, A. (2015). Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. (Doctoral Dissertation). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/4937

Chicago Manual of Style (16th Edition):

Cameron, Alanna. “Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.” 2015. Doctoral Dissertation, Victoria University of Wellington. Accessed September 19, 2019. http://hdl.handle.net/10063/4937.

MLA Handbook (7th Edition):

Cameron, Alanna. “Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy.” 2015. Web. 19 Sep 2019.

Vancouver:

Cameron A. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. [Internet] [Doctoral dissertation]. Victoria University of Wellington; 2015. [cited 2019 Sep 19]. Available from: http://hdl.handle.net/10063/4937.

Council of Science Editors:

Cameron A. Targeted BRAF inhibitors: Immunological effects and combination with immunotherapy. [Doctoral Dissertation]. Victoria University of Wellington; 2015. Available from: http://hdl.handle.net/10063/4937

[1] [2] [3] [4] [5] … [29]

.